{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:40:23Z","timestamp":1793356823404,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011676","name":"Elekta AB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011676","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.ctro.2026.101287","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:32:34Z","timestamp":1789169554000},"page":"101287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Daily adaptive 1.5\u00a0T MR-Linac image-guided re-irradiation for prostate cancer: an international retrospective experience"],"prefix":"10.1016","volume":"62","author":[{"given":"Sian","family":"Cooper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria Sarah","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Alongi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Chick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gorovets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trina","family":"Herbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Kollmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Nagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Nicosia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Romei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Tree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochem","family":"van der Voort van Zyp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Pathmanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2026.101287_bb0005","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","article-title":"The lancet commission on prostate cancer: planning for the surge in cases","volume":"403","author":"James","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2026.101287_bb0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11864-024-01181-9","article-title":"Impact of PSMA PET on prostate cancer management","volume":"25","author":"Weiner","year":"2024","journal-title":"Curr. Treat. Options in Oncol."},{"key":"10.1016\/j.ctro.2026.101287_bb0015","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.critrevonc.2013.07.009","article-title":"Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: a review","volume":"88","author":"Alongi","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ctro.2026.101287_bb0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-068580","article-title":"Reirradiation options for previously irradiated prostate cancer (RO-PIP): feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT)","volume":"12","author":"Zhong","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.ctro.2026.101287_bb0025","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.eururo.2020.11.010","article-title":"A systematic review and Meta-analysis of local salvage therapies after radiotherapy for prostate Cancer (MASTER)","volume":"80","author":"Valle","year":"2021","journal-title":"Eur. Urol."},{"issue":"6","key":"10.1016\/j.ctro.2026.101287_bb0030","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jamaoncol.2026.1023","article-title":"Local salvage therapy alone for local recurrence of prostate cancer after radiotherapy: a systematic review and meta-analysis","volume":"12","author":"Miszczyk","year":"2026","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ctro.2026.101287_bb0035","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/phar.2168","article-title":"Risks of major long-term side effects associated with androgen-deprivation therapy in men with prostate Cancer","volume":"38","author":"Nguyen","year":"2018","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ctro.2026.101287_bb0040","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s00432-020-03297-5","article-title":"PROLAPSE: survey about local prostate cancer relapse salvage treatment with external beam re-irradiation: results of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)","volume":"146","author":"Zerini","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ctro.2026.101287_bb0045","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijrobp.2017.10.020","article-title":"Magnetic resonance imaging-guided adaptive radiation therapy: a \u201cgame changer\u201d for prostate treatment?","volume":"100","author":"Pathmanathan","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctro.2026.101287_bb0050","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ctro.2019.04.001","article-title":"Adaptive radiotherapy: the Elekta Unity MR-linac concept","volume":"18","author":"Winkel","year":"2019","journal-title":"Clinical and Translational Radiation Oncology"},{"key":"10.1016\/j.ctro.2026.101287_bb0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctro.2026.101287_bb0060","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctro.2026.101287_bb0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.clon.2022.09.047","article-title":"Launch of the UK SABR consortium pelvic stereotactic ablative radiotherapy re-irradiation guidelines and National Audit","volume":"35","author":"Muirhead","year":"2023","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.ctro.2026.101287_bb0070","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.radonc.2021.09.010","article-title":"An international Delphi consensus for pelvic stereotactic ablative radiotherapy re-irradiation","volume":"164","author":"Slevin","year":"2021","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctro.2026.101287_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102206","article-title":"Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: an ESTRO ACROP Delphi consensus","volume":"98","author":"Jereczek-Fossa","year":"2021","journal-title":"Cancer Treat. Rev."},{"issue":"2","key":"10.1016\/j.ctro.2026.101287_bb0080","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijrobp.2025.01.038","article-title":"Joining Forces to Advance Reirradiation: Establishing the Reirradiation COllaborative Group (ReCOG)","volume":"122","author":"Mayo","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.ctro.2026.101287_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.01328","article-title":"The MOMENTUM study: an international registry for the evidence-based introduction of MR-guided adaptive therapy","volume":"10","author":"de Mol van Otterloo","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctro.2026.101287_bb0090","series-title":"AJCC cancer staging manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.ctro.2026.101287_bb0095","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the eastern cooperative oncology group","volume":"5","author":"Oken","year":"1982","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.ctro.2026.101287_bb0100","series-title":"International Prostate Symptom Score (I-PSS)","author":"British Association of Urological Surgeons","year":"2026"},{"key":"10.1016\/j.ctro.2026.101287_bb0105","series-title":"Common Terminology Criteria for Adverse Events (CTCAE)v4","author":"U.S. Department of health and human services","year":"2017"},{"key":"10.1016\/j.ctro.2026.101287_bb0110","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix consensus conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctro.2026.101287_bb0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13014-020-01510-w","article-title":"1.5T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment","volume":"15","author":"Alongi","year":"2020","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.ctro.2026.101287_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.858740","article-title":"1.5T MR-guided daily adaptive stereotactic body radiotherapy for prostate re-irradiation: a preliminary report of toxicity and clinical outcomes","volume":"12","author":"Cuccia","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctro.2026.101287_bb0125","first-page":"35","article-title":"Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: initial clinical experiences and assessment of delivered doses compared to a C-arm linac","volume":"23","author":"Dunlop","year":"2020","journal-title":"Clin Transl Radiat Oncol."},{"key":"10.1016\/j.ctro.2026.101287_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111087","article-title":"Magnetic resonance guided stereotactic reirradiation for locally recurrent prostate cancers: long-term results from a prospective registry study","volume":"211","author":"Buchalet","year":"2025","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctro.2026.101287_bb0135","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejmp.2020.09.026","article-title":"Adaptive SBRT by 1.5 T MR-linac for prostate cancer: on the accuracy of dose delivery in view of the prolonged session time","volume":"80","author":"Ruggieri","year":"2020","journal-title":"Phys Med"},{"key":"10.1016\/j.ctro.2026.101287_bb0140","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijrobp.2022.08.030","article-title":"The fraction size sensitivity of late genitourinary toxicity: analysis of alpha\/Beta (\u03b1\/\u03b2) ratios in the CHHiP trial","volume":"115","author":"Brand","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctro.2026.101287_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110535","article-title":"Intra-prostatic recurrences after radiotherapy with focal boost: location and dose mapping in the FLAME trial","volume":"201","author":"Menne Guricov\u00e1","year":"2024","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctro.2026.101287_bb0150","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijrobp.2016.11.026","volume":"98","author":"Morris","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctro.2026.101287_bb0155","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13014-022-02010-9","article-title":"Variability of \u03b1\/\u03b2 ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy","volume":"17","author":"Cui","year":"2022","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.ctro.2026.101287_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111313","article-title":"Cumulative dose evaluation in clinical reirradiation - consensus guidance on technical considerations by the ESTRO reirradiation focus group","volume":"214","author":"Appelt","year":"2026","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctro.2026.101287_bb0165","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.294.2.238","article-title":"Androgen deprivation therapy for prostate Cancer","volume":"294","author":"Sharifi","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ctro.2026.101287_bb0170","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1200\/JCO.23.01391","article-title":"Salvage Reirradiation for locally recurrent prostate Cancer: results from a prospective study with 7.2 years of follow-up","volume":"42","author":"Ekanger","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctro.2026.101287_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111138","article-title":"Re-irradiation in patients affected by prostate cancer and relapsing after previous definitive or postoperative radiotherapy. An international registry based study on behalf of Italian association of radiotherapy and clinical oncology (AIRO). (RE-START)","volume":"212","author":"Francolini","year":"2025","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctro.2026.101287_bb0180","series-title":"Magnetic Resonance-Guided Reirradiation for Local Recurrence within the Prostate or in the Prostate Bed: One-Year Clinical Results of a Prospective Registry Study - PMC","author":"Anon","year":"2026"},{"key":"10.1016\/j.ctro.2026.101287_bb0185","article-title":"Re-irradiation to the prostate using stereotactic body radiotherapy (SBRT) after initial definitive radiotherapy - a systematic review and meta-analysis of recent trials","volume":"48","author":"Schr\u00f6der","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101287_bb0190","article-title":"Salvage stereotactic MR-guided adaptive radiotherapy (SMART) re-irradiation for locally recurrent prostate cancer: clinical and dosimetric outcomes","volume":"56","author":"Moreno-Olmedo","year":"2026","journal-title":"ctRO"},{"key":"10.1016\/j.ctro.2026.101287_bb0195","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.3747\/co.22.2247","article-title":"Acute toxicity of hypofractionated intensity-modulated radiotherapy for prostate cancer","volume":"22","author":"Drodge","year":"2015","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.ctro.2026.101287_bb0200","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1078-0432.CCR-08-1754","article-title":"Disseminated tumor cells in prostate cancer patients after radical prostatectomy and without evidence of disease predicts biochemical recurrence","volume":"15","author":"Morgan","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ctro.2026.101287_bb0205","article-title":"Radical prostatectomy versus stereotactic radiotherapy for clinically localised prostate cancer: results of the PACE-A randomised trial","volume":"86","author":"van A","year":"2024","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ctro.2026.101287_bb0210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40644-023-00543-0","article-title":"Outcome of patients with biochemical recurrence of prostate cancer after PSMA PET\/CT-directed radiotherapy or surgery without systemic therapy","volume":"23","author":"Harsini","year":"2023","journal-title":"Cancer Imaging"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:04:40Z","timestamp":1793354680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826001825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":42,"alternative-id":["S2405630826001825"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101287","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Daily adaptive 1.5\u00a0T MR-Linac image-guided re-irradiation for prostate cancer: an international retrospective experience","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101287"}}